Mexico said it aimed to vaccinate 90 percent of its population against the coronavirus by the end of 2021 after signing deals Tuesday worth $1.66 billion with major pharmaceutical companies.
Together with potential vaccines from a World Health Organization-backed program, the agreements with AstraZeneca, Pfizer and CanSinoBio could enable Mexico to vaccine up to 116 million people, the government said.
The country of around 128 million has officially registered 83,945 deaths from Covid-19, the world’s fourth-highest toll.
The vaccines, which are still undergoing clinical trials, are among dozens that researchers around the world are racing to prove safe and effective.
Mexican President Andres Manuel Lopez Obrador told a news conference that vaccination would be made available “for the entire population free of charge.”
The program could start in December with the first batches from Pfizer of the United States and CanSinoBio of China, and last one year, according to Finance Minister Arturo Herrera.
Priority will be given to medical personnel and vulnerable groups.
Mexico has also signed up to the Covax mechanism, which is backed by the WHO and aims to facilitate poor countries’ access to coronavirus vaccines.
Mexico joins WHO coronavirus vaccine plan
© 2020 AFP
Mexico aims to vaccinate 90% of population by end of 2021 (2020, October 13)
retrieved 14 October 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- Here’s everything you need to know about the third dose of vaccination - September 28, 2021
- Herbal drug Fifatrol fights viral infection, says BHU ayurveda expert - September 28, 2021
- ICMR experts favour phased reopening of schools with multi-layered Covid mitigation steps - September 28, 2021
- World Heart Day: The 3 key solutions to address Congenital Heart Disease in Rural India - September 28, 2021
- Smoking may increase risk of COVID-19 severity, death, study finds - September 28, 2021
- New AIIMS will correct regional imbalance: Union minister Nitin Gadkari - September 27, 2021
- AstraZeneca Pharma India gets DCGI nod to import, market Selumetinib capsules - September 27, 2021
- Over 84.50 crore Covid vaccine doses provided to states, UTs: Centre - September 27, 2021
- Improving access to contraception in post Covid world - September 27, 2021
- PM Modi launches digital health mission - September 27, 2021